CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
1996 • 5,667 citations
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
1999 • 1,865 citations
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
1994 • 1,542 citations
The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers
1996 • 1,008 citations
The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer
1996 • 547 citations
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
2001 • 379 citations
DNA methylation and gene silencing in cancer: which is the guilty party?
2002 • 288 citations
Muir–Torre-like syndrome in Fhit-deficient mice
2000 • 178 citations
FRA3B and other common fragile sites: the weakest links
2001 • 177 citations
Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction Assay
2001 • 172 citations
The tumor spectrum in FHIT- deficient mice
2001 • 164 citations
FHIT gene therapy prevents tumor development in Fhit-deficient mice
2001 • 129 citations
DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras
2003 • 92 citations
Loss of FHIT Expression in Transitional Cell Carcinoma of the Urinary Bladder
2000 • 66 citations
The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells
2001 • 43 citations
Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome
2003 • 33 citations
Cited By (0)
No citing papers found in database